Baker Bros. Advisors LP Ab Cellera Biologics Inc. Transaction History
Baker Bros. Advisors LP
- $9.34 Billion
- Q3 2024
A detailed history of Baker Bros. Advisors LP transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 27,525,640 shares of ABCL stock, worth $81.2 Million. This represents 0.76% of its overall portfolio holdings.
Number of Shares
27,525,640
Previous 27,525,640
-0.0%
Holding current value
$81.2 Million
Previous $81.5 Million
12.5%
% of portfolio
0.76%
Previous 1.08%
Shares
5 transactions
Others Institutions Holding ABCL
# of Institutions
154Shares Held
109MCall Options Held
153KPut Options Held
194K-
Baillie Gifford & CO12.9MShares$38 Million0.03% of portfolio
-
Voya Investment Management LLC Atlanta, GA10.6MShares$31.3 Million0.03% of portfolio
-
Prosight Management, LP Dallas, TX9.08MShares$26.8 Million6.31% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL4.59MShares$13.5 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V84.55MShares$13.4 Million0.02% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $841M
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...